Artelo Biosciences settles with activist investor Daniel Farb; he withdraws board nominations

ARTELO BIOSCIENCES, INC.

Daniel S. Farb and affiliates irrevocably withdraw director nominations for 2025 annual meeting (letter dated Sept 19, 2025).
Farb Group agrees to standstill, voting commitments in favor of Board nominees, and caps beneficial ownership at 8% of outstanding stock.
Mutual non-disparagement obligations and full mutual release of claims through date of agreement.
Company to reimburse Farb Group up to $90,000 for documented out-of-pocket expenses.
Farb gets opportunity to present value-creation ideas to Board at next regular or special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.